EyeGate Pharmaceuticals, Inc. (EYEG) - Medical Equipment - Deals and Alliances Profile

Date: August 16, 2016
Pages: 31
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E4124A0F9DAEN
Leaflet:

Download PDF Leaflet

EyeGate Pharmaceuticals, Inc. (EYEG) - Medical Equipment - Deals and Alliances Profile
Summary

EyeGate Pharmaceuticals, Inc. (EyeGate) is a pharmaceutical and drug delivery company that develops and commercialize therapeutics and drug delivery mechanisms. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient adherence and patient safety. EyeGate deliver drugs in optimal dosing regimens directly into the ocular tissue in both the anterior and posterior segments of the eye. The company offers EGP-437 that incorporates a reformulated corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues. It offers developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye. EyeGate is headquartered in Waltham, Massachusetts, the US.

EyeGate Pharmaceuticals, Inc. (EYEG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

    Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

    Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

    Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

    Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.

    Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company.
  • EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deal Details
    Venture Financing
    EyeGate Pharma Raises USD2.6 Million in Venture Financing
    EyeGate Pharma Raises US$1 Million In Venture Financing
    EyeGate Pharma Secures An Additional US$5.9 Million In Series D Round Of Financing
    EyeGate Pharma Secures An Additional US$11.6 Million In Series D Round Of Financing
    Partnerships
    Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents
    Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
    EyeGate Pharmaceuticals, Inc. - Key Competitors
    Key Employees
    Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Recent Developments
    Financial Announcements
    Aug 10, 2016: EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update
    May 13, 2016: Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update
    Mar 29, 2016: EyeGate Reports Full-year 2015 Financial Results and Provides Business Update
    Nov 12, 2015: EyeGate Reports Third Quarter 2015 Financial Results and Provides Business Update
    Mar 31, 2015: EyeGate Pharmaceuticals Reports Full Year 2014 Financial Results
    Corporate Communications
    May 06, 2016: EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and Development
    Apr 27, 2016: EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial Officer
    Mar 02, 2015: Eyegate Pharmaceuticals Names Michael B. Raizman, MD, Consulting Chief Medical Officer
    Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    EyeGate Pharmaceuticals, Inc., Medical Equipment, Key Facts, 2015
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Deals By Market, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
    EyeGate Pharma Raises USD2.6 Million in Venture Financing
    EyeGate Pharma Raises US$1 Million In Venture Financing
    EyeGate Pharma Secures An Additional US$5.9 Million In Series D Round Of Financing
    EyeGate Pharma Secures An Additional US$11.6 Million In Series D Round Of Financing
    Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents
    Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
    EyeGate Pharmaceuticals, Inc., Key Competitors
    EyeGate Pharmaceuticals, Inc., Key Employees
    EyeGate Pharmaceuticals, Inc., Subsidiaries

    LIST OF FIGURES

    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
    EyeGate Pharmaceuticals, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    EyeGate Pharmaceuticals, Inc. (EYEG) - Medical Equipment - Deals and Alliances Profile
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: